FC

Finepoint Capital Portfolio holdings

AUM $504M
This Quarter Return
+36.69%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$289M
AUM Growth
+$289M
Cap. Flow
+$7.08M
Cap. Flow %
2.45%
Top 10 Hldgs %
74.1%
Holding
32
New
1
Increased
6
Reduced
1
Closed
5

Top Buys

1
LBRDK icon
Liberty Broadband Class C
LBRDK
$14.9M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$6.67M
3
RVMD icon
Revolution Medicines
RVMD
$5.45M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
$4.95M
5
RLAY icon
Relay Therapeutics
RLAY
$4.92M

Top Sells

1
HPLTW
Home Plate Acquisition Corporation Warrant
HPLTW
$21.7M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$12.3M
3
AAC.WS
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$334K
4
BTWNW
Bridgetown Holdings Limited Warrants
BTWNW
$304K
5
CCVI.WS
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$86.4K

Sector Composition

1 Healthcare 87.85%
2 Communication Services 5.14%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CYTK icon
1
Cytokinetics
CYTK
$4.23B
$36M 11.37% 431,693 – –
ACAD icon
2
Acadia Pharmaceuticals
ACAD
$4.38B
$24.1M 7.6% 769,653 +213,100 +38% +$6.67M
FOLD icon
3
Amicus Therapeutics
FOLD
$2.34B
$21.1M 6.67% 1,489,025 – –
ARVN icon
4
Arvinas
ARVN
$568M
$20.8M 6.55% 504,700 – –
ASND icon
5
Ascendis Pharma
ASND
$11.8B
$20.6M 6.51% 163,772 – –
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$20.3M 6.41% 556,928 – –
HPLTW
7
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$20M 6.31% 331,416 -358,584 -52% -$21.7M
GLPG icon
8
Galapagos
GLPG
$2.07B
$18.6M 5.88% 458,659 – –
RVMD icon
9
Revolution Medicines
RVMD
$7.1B
$17.7M 5.58% 617,100 +190,100 +45% +$5.45M
LBRDK icon
10
Liberty Broadband Class C
LBRDK
$8.73B
$14.9M 4.69% +184,460 New +$14.9M
RLAY icon
11
Relay Therapeutics
RLAY
$619M
$14.5M 4.58% 1,317,870 +447,000 +51% +$4.92M
MORF
12
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$14.3M 4.53% 496,856 +171,500 +53% +$4.95M
SRPT icon
13
Sarepta Therapeutics
SRPT
$1.78B
$14M 4.42% 145,357 – –
TVTX icon
14
Travere Therapeutics
TVTX
$1.56B
$12.9M 4.07% 1,435,321 +539,500 +60% +$4.85M
PRTA icon
15
Prothena Corp
PRTA
$441M
$12.7M 4% 349,300 – –
SLDB icon
16
Solid Biosciences
SLDB
$427M
$5.9M 1.86% 961,251 – –
CLDI icon
17
Calidi Biotherapeutics
CLDI
$8.83M
$189K 0.06% 125,000 – –
CVIIW
18
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$71.3K 0.02% 548,000 – –
MLTX icon
19
MoonLake Immunotherapeutics
MLTX
$3.54B
$62.7K 0.02% 895,000 +563,584 +170% +$39.5K
CNDA.WS
20
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$53.1K 0.02% 408,333 – –
CLDI.WS
21
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$32.8K 0.01% 655,200 – –
ROSS.WS
22
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$24.6K 0.01% 439,666 – –
CDAQW
23
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$22.3K 0.01% 459,906 – –
GATEW
24
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$22.1K 0.01% 735,000 – –
IVCPW
25
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$20.1K 0.01% 490,000 – –
1
2